Ariad Pharmaceuticals Aktie
WKN: 895301 / ISIN: US04033A1007
03.11.2015 13:37:58
|
EARNINGS SUMMARY: Details of Ariad Pharmaceuticals Inc Q3 Earnings Report
(RTTNews) - Below are the earnings highlights for Ariad Pharmaceuticals Inc (ARIA):
-Earnings: -$55.45 million in Q3 vs. -$50.11 million in the same period last year. -EPS: -$0.29 in Q3 vs. -$0.27 in the same period last year. -Analysts projected -$0.23 per share -Revenue: $29.07 million in Q3 vs. $14.68 million in the same period last year.
-Guidance: Full year revenue guidance: $130 - $140 Mln

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Ariad Pharmaceuticals Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |